Tempest Therapeutics Inc (TPST) is higher by Thursday morning, with the stock adding 3.30% in pre-market trading to 3.44. TPST's short-term technical score of 56 indicates that the stock has traded more bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 127 out of 146 industries, Tempest Therapeutics Inc ranks higher than 74% of stocks. Tempest Therapeutics Inc has fallen 14.18% over the past month, closing at $3.84 on November 2. During this period of time, the stock fell as low as $2.82 and as high as $4.43. TPST has an average analyst recommendation of Strong Buy. The company has an average price target of $21.67.
TPST has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on TPST!